Chemcrux Enterprises Ltd manufactures and processes bulk drug intermediatesBusiness Overview: CEL is an ISO 9001:2015, ISO 14001:2015 and ISO 50001:2018 certified company. It specializes in High Pressure Oxidation, Nitration, Chlorosulfonation and Amidation Chemistry - manufacturing intermediates for bulk drugs(API), dyes & pigment, electro-plating, pharmaceuticals, dyes and pigments industries
CHEMCRUX ENTERPRISES LIMITED has released its standalone and consolidated financial results for the quarter ended 30th June 2025. These crucial performance indicators, which have undergone a limited review by statutory auditors and were approved by the Board, are now publicly available. This announcement provides investors with key insights into the...
Chemcrux Enterprises Limited's Chief Financial Officer, Mr. Ramesh Kambariya, has resigned from his position, effective August 11. He stated his decision to pursue opportunities offering personal financial growth. This change in a key management role will require the company to ensure a smooth transition for its financial leadership. Shareholders should...
Chemcrux has announced a board meeting where it approved the financial results for the quarter. Key proposals include increasing authorized share capital from Rs 15 Cr to Rs 20 Cr and introducing an ESOP scheme for 20 lakh options to eligible employees, both subject to shareholder approval. The board also...
CHEMCRUX's Board has approved its financial results for the quarter. Key approvals include the proposed appointment of KSPS & Co. LLP as Secretarial Auditor and the continuation of Mr. Girishkumar Shah (Executive Chairman), Mr. Sanjay Marathe (Managing Director), and Mr. Bhanubhai Patel (Independent Director), all subject to shareholder approval. The...
Chemcrux Enterprises has announced a board meeting outcome revealing several key strategic decisions. The company approved its financial results for the quarter, following review by the Audit Committee. The board also proposed the appointment of a new Secretarial Auditor and the continuity of its Executive Chairman, Managing Director, and an...
